Elevated serum IL-6 levels were positively correlated with tumor load and disease progression, and IL-6 levels were significantly elevated in patients with gastric cancer with lymph node metastasis [28]. The gene discussed is IL6; the disease is metastatic malignant neoplasm in the lymph nodes.